Total Payments
$836.79
2022 Payments
$131.60
Companies
13
Transactions
23
Medicare Patients
3,734
Medicare Billing
$646,203
Payment Breakdown by Category
Food & Beverage$786.84 (94.0%)
Education$49.95 (6.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $786.84 | 22 | 94.0% |
| Education | $49.95 | 1 | 6.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Fresenius USA Marketing, Inc. | $174.97 | 3 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $167.03 | 5 | $0 (2022) |
| Otsuka America Pharmaceutical, Inc. | $141.55 | 3 | $0 (2022) |
| Relypsa, Inc. | $102.21 | 2 | $0 (2018) |
| NxStage Medical, Inc. | $66.36 | 1 | $0 (2019) |
| BAXTER HEALTHCARE | $49.61 | 1 | $0 (2018) |
| Amgen Inc. | $40.38 | 2 | $0 (2020) |
| Vifor Pharma, Inc. | $17.83 | 1 | $0 (2022) |
| Aurinia Pharma U.S., Inc. | $17.32 | 1 | $0 (2022) |
| Bayer HealthCare Pharmaceuticals Inc. | $17.04 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $131.60 | 6 | AstraZeneca Pharmaceuticals LP ($65.61) |
| 2021 | $17.10 | 1 | AstraZeneca Pharmaceuticals LP ($17.10) |
| 2020 | $174.01 | 3 | Fresenius USA Marketing, Inc. ($161.00) |
| 2019 | $269.30 | 5 | Otsuka America Pharmaceutical, Inc. ($105.00) |
| 2018 | $190.38 | 5 | Relypsa, Inc. ($102.21) |
| 2017 | $54.40 | 3 | Amgen Inc. ($27.37) |
All Payment Transactions
23 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/14/2022 | Vifor Pharma, Inc. | Veltassa (Drug), Korsuva | Food and Beverage | In-kind items and services | $17.83 | General |
| Category: Hyperkalemia | ||||||
| 11/08/2022 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Education | In-kind items and services | $49.95 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/19/2022 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $13.80 | General |
| Category: NEPHROLOGY | ||||||
| 08/01/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.04 | General |
| Category: Cardio-renal | ||||||
| 06/27/2022 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $17.32 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 04/12/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.66 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/29/2021 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $17.10 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/28/2020 | Fresenius USA Marketing, Inc. | — | Food and Beverage | In-kind items and services | $121.43 | General |
| 02/28/2020 | Fresenius USA Marketing, Inc. | — | Food and Beverage | In-kind items and services | $39.57 | General |
| 01/15/2020 | Amgen Inc. | Parsabiv (Drug) | Food and Beverage | In-kind items and services | $13.01 | General |
| Category: Nephrology | ||||||
| 08/22/2019 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $44.32 | General |
| 08/14/2019 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $40.00 | General |
| 06/13/2019 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $105.00 | General |
| Category: NEPHROLOGY | ||||||
| 05/16/2019 | bioMerieux | — | Food and Beverage | In-kind items and services | $13.62 | General |
| 04/11/2019 | NxStage Medical, Inc. | SYSTEM ONE (Device) | Food and Beverage | In-kind items and services | $66.36 | General |
| Category: Nephrology | ||||||
| 11/15/2018 | BAXTER HEALTHCARE | Renal - Non Product Related (Biological) | Food and Beverage | In-kind items and services | $49.61 | General |
| Category: Renal | ||||||
| 10/25/2018 | Mallinckrodt LLC | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $15.81 | General |
| Category: AUTOIMMUNE AND RARE DISEASE | ||||||
| 08/21/2018 | Relypsa, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $18.11 | General |
| Category: Hyperkalemia | ||||||
| 06/13/2018 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $22.75 | General |
| Category: NEPHROLOGY | ||||||
| 01/08/2018 | Relypsa, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $84.10 | General |
| Category: Hyperkalemia | ||||||
| 09/11/2017 | OPKO Pharmaceuticals, LLC | Rayaldee (Drug) | Food and Beverage | In-kind items and services | $13.06 | General |
| Category: Hyperparathyroidism | ||||||
| 05/22/2017 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $13.97 | General |
| Category: Phosphate binder for ESRD | ||||||
| 04/24/2017 | Amgen Inc. | Parsabiv (Biological), Sensipar | Food and Beverage | In-kind items and services | $27.37 | General |
| Category: Nephrology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 748 | 1,645 | $466,742 | $141,646 |
| 2022 | 14 | 898 | 1,741 | $493,857 | $143,659 |
| 2021 | 13 | 1,058 | 2,167 | $582,763 | $188,306 |
| 2020 | 14 | 1,030 | 2,038 | $649,115 | $172,592 |
Total Patients
3,734
Total Services
7,591
Medicare Billing
$646,203
Procedure Codes
52
All Medicare Procedures & Services
52 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 21 | 134 | $127,300 | $34,751 | 27.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 155 | 574 | $91,266 | $33,738 | 37.0% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 96 | 259 | $58,534 | $22,843 | 39.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 151 | 269 | $62,677 | $14,363 | 22.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 100 | 103 | $46,144 | $12,941 | 28.0% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 16 | 27 | $25,650 | $5,823 | 22.7% |
| 76770 | Complete ultrasound scan behind abdominal cavity | Office | 2023 | 75 | 75 | $16,875 | $4,807 | 28.5% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 37 | 95 | $9,120 | $3,453 | 37.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 26 | 26 | $12,740 | $3,436 | 27.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 48 | 59 | $8,732 | $3,218 | 36.8% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 23 | 24 | $7,704 | $2,272 | 29.5% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 20 | 109 | $103,550 | $28,936 | 27.9% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 185 | 499 | $79,341 | $26,454 | 33.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 167 | 310 | $72,230 | $17,952 | 24.9% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 118 | 124 | $55,552 | $17,818 | 32.1% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 95 | 230 | $51,980 | $17,638 | 33.9% |
| 76770 | Complete ultrasound scan behind abdominal cavity | Office | 2022 | 104 | 104 | $23,400 | $8,202 | 35.1% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2022 | 12 | 27 | $25,650 | $5,885 | 22.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 31 | 31 | $15,190 | $4,837 | 31.8% |
| 90945 | Dialysis procedure including 1 evaluation | Facility | 2022 | 11 | 75 | $27,375 | $4,827 | 17.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 47 | 61 | $9,028 | $3,645 | 40.4% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 24 | 29 | $9,309 | $2,910 | 31.3% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 43 | 92 | $8,832 | $2,642 | 29.9% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2022 | 25 | 28 | $10,220 | $1,535 | 15.0% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 16 | 22 | $2,200 | $376.28 | 17.1% |
About Dr. Shilpa Carlson, DO
Dr. Shilpa Carlson, DO is a Nephrology healthcare provider based in Nashville, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/17/2007. The National Provider Identifier (NPI) number assigned to this provider is 1811104003.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Shilpa Carlson, DO has received a total of $836.79 in payments from pharmaceutical and medical device companies, with $131.60 received in 2022. These payments were reported across 23 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($786.84).
As a Medicare-enrolled provider, Carlson has provided services to 3,734 Medicare beneficiaries, totaling 7,591 services with total Medicare billing of $646,203. Data is available for 4 years (2020–2023), covering 52 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Location Nashville, TN
- Active Since 05/17/2007
- Last Updated 10/29/2025
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1811104003
Products in Payments
- JYNARQUE (Drug) $141.55
- Veltassa (Drug) $120.04
- LOKELMA (Drug) $67.05
- SYSTEM ONE (Device) $66.36
- Renal - Non Product Related (Biological) $49.61
- Parsabiv (Biological) $27.37
- LUPKYNIS (Drug) $17.32
- Kerendia (Drug) $17.04
- ACTHAR (Biological) $15.81
- FARXIGA (Drug) $15.66
- Velphoro (Drug) $13.97
- Rayaldee (Drug) $13.06
- Parsabiv (Drug) $13.01
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Nashville
Dr. Jamie Dwyer, M.d, M.D
Nephrology — Payments: $549,974
Nephrology $549,974
Talat Ikizler, Md, MD
Nephrology — Payments: $240,153
Nephrology $240,153
Julia Lewis, Md, MD
Nephrology — Payments: $126,571
Nephrology $126,571
Dr. Volker Haase, M.d, M.D
Nephrology — Payments: $125,972
Nephrology $125,972
Alfred George, Md, MD
Nephrology — Payments: $51,836
Nephrology $51,836
Dr. Thomas Golper, Md, MD
Nephrology — Payments: $33,757
Nephrology $33,757